Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model

Authors

Keywords

Journal

Volume 36, Issue 6, Pages 355-361

Publisher

Elsevier BV

Online

2009-06-17

DOI

10.1016/s1673-8527(08)60124-1

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started